New medicines for both body and mind are
being developed everyday and new applications of ancient drugs are gaining recognition in
the medical field. In particular, advances in brain research and the study
of brain chemistry are introducing novel possibilities for
neurotherapy, neuropharmacology an even neurotheology.
Drug laws and regulations must be carefully analyzed and crafted to
preserve an open scientific forum for pharmacological research. The
recommendations of doctors and researchers should take precedent over law
enforcement. Ultimately, the system should empower individuals to make
intelligent and informed decisions about the drugs they decide to take.
Under no circumstances should individuals be compelled to take certain
drugs, nor be prohibited from doing so, so long as they do not engage in
behavior that harms others. The CCLE supports innovation in
pharmacological research and application, and respects the cognitive
liberty of those who wish to use both ancient and modern medicines in
Ask Dr. Shulgin
Depression: Drug Deals for Drug Makers
"On July 14th, 2002, in an unprecedented alchemy of
corporate drug deals synthesized behind closed doors, a $60 billion
transaction allowed Pfizer Inc. to acquire Pharmacia Corporation, creating
the largest pharmaceutical company in the world. With anticipated annual
revenues of $48 billion, the newly concocted Pfizer-Pharmacia mega-company
will have unsurpassed global dominance on some of the most lucrative
pharmaceutical drugs available on the market. The potential side effects
of the merger on consumers, seems to have gone unnoticed."
for Drug Evaluation and Research
FDA's site for information about newly approved
on Law and Values in Health Environment and the Life Sciences
"The mission of the Consortium is to support work on the
legal, ethical, and policy implications of problems in health,
environment, and the life sciences. Our goal is to advance knowledge,
public understanding, and sound policy."
Drug Approvals List
Learn which new drugs the FDA has just
Food and Drug Law
FDLI is a nonprofit educational organization dedicated to improving the
understanding of the laws, regulations, and policies affecting healthcare
technologies, food and cosmetics. FDLI is neutral, nonpartisan and does
not lobby or advocate positions on any issue.
A membership organization that funds pioneering scientific research aimed
at achieving an indefinitely extended healthy human lifespan.
Association for Psychedelic Studies (MAPS)
MAPS' goals are to promote scientific research designed to evaluate
psychedelics and marijuana as potential prescription medicines, and to
educate the public honestly about the risks and benefits of these drugs.
Research and Manufacturers of America
Their policy page offers viewpoints
on the issue of intellectual property patents in regards to new
Phamacology Portal with news on new drugs
Provigil is a new drug that some people find enhances cognition.
If you would like to expound on
any of these issues or suggest additional resources, please contact us at
Receive Top News
Alerts in your E-mail box!